Closed Drug Transfer for Oncology TherapeuticsGreystone Research AssociatesJune 15, 2010 43 Pages - SKU: GRST2879987 |
|
The World Market for Orphan Drugs
6/13/2013 | published by: Kalorama Information
In recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this trend and
|
read more...
|
$4,500.00
|
|
The World Market for Pain Management Drugs and Devices
5/20/2013 | published by: Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and
|
read more...
|
$3,500.00
|
|
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,
|
read more...
|
$4,500.00
|
|
Triple Analysis: Melanoma, Apoptosis and Protein Kinase Inhibitors
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria
|
read more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Melanoma and Antibodies
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according to standardized criteria in
|
read more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Melanoma and Apoptosis
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according to standardized criteria in a
|
read more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Melanoma and Prostate Cancer
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment
|
read more...
|
$5,175.00
|
|
Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria
|
read more...
|
$5,175.00
|
|
Antibody Drug Conjugates Market, 2012-2023
5/31/2013 | published by: Roots Analysis Pvt. Ltd.
Antibody Drug Conjugates (ADC) are a new class of biologic therapeutics. These are complex molecules comprising of an antibody linked to few cytotoxin molecules through linker technology. This class of biologics is attracting the attention
|
read more...
|
$1,699.00
|
|
Triple Analysis: Leukemia, Melanoma and Apoptosis
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according to standardized criteria in a five
|
read more...
|
$5,175.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
- Biotechnology
- Antibody Technologies
- Pharmaceuticals
- Regulation & Policy
- Research & Development
- Therapeutic Area
- Oncology/Hematology
Oncology/Hematology Reports